Skip to main content
. 2019 Jan 4;10(3):248–254. doi: 10.1021/acsmedchemlett.8b00395

Figure 1.

Figure 1

Structures of known NMDAR channel blockers and negative allosteric modulators; memantine (1), dextromethorphan (2), amantadine (3), ketamine (4) ifenprodil (5),8,9 DQP-110511 (6), QNZ-4610 (7), NAB-1415 (8), TCN-20113 (9, a GluN2A-selective negative allosteric modulator that acts by reducing glycine affinity), and EVT-101 (10).16